Molecular data
| Physical form | Lyophilized powder blend |
|---|---|
| Available sizes | 5mg / 5mg, 10mg / 10mg |
How it works
-
Selank
Anxiolytic-Like Signalling
Selank is a synthetic analog of the immunomodulatory peptide tuftsin. GABAergic signalling and anxiolytic-like endpoints are the characterised readouts in rodent models, alongside effects on enkephalin degradation.
- Tuftsin analog
- GABAergic signalling
- Anxiolytic-like endpoints
-
Semax
BDNF Expression & Neuroprotection
Semax is an ACTH(4-10) analog without corticotropic activity. Elevated BDNF and NGF expression is measured in rodent hippocampus, and neuroprotective endpoints are characterised in ischaemia models.
- ACTH(4-10) analog
- BDNF / NGF expression
- Neuroprotection endpoints
-
Combined
Shared Research Lineage
Both peptides come from the same Russian research lineage and are frequently studied in parallel. The combination itself has not been characterised.
- Same research lineage
- Frequently studied in parallel
- Interaction not characterised
What the research shows
-
Neuroscience
Anxiolytic Models
Selank is characterised for anxiolytic-like endpoints in standard rodent behavioural models.
-
Neuroscience
Neurotrophic Expression
Semax is studied for BDNF and NGF expression in rodent hippocampus.
-
Neuroscience
Ischaemia Models
Neuroprotective endpoints for Semax are characterised in cerebral ischaemia research.
-
Methods
Parallel Protocols
One vial holds both peptides under matched handling for parallel work.
Specification
| Components | Selank + Semax |
|---|---|
| Selank Sequence | Thr-Lys-Pro-Arg-Pro-Gly-Pro (tuftsin analog) |
| Semax Sequence | Met-Glu-His-Phe-Pro-Gly-Pro (ACTH 4-10 analog) |
| Form | Lyophilized powder blend |
| Purity | ≥99% by HPLC |
| Appearance | White to off-white powder |
| Solubility | Water-soluble |
| Storage | -20°C, protected from light |
| Classification | Research use only |
Frequently asked questions
Why combine Selank and Semax?
Both are heptapeptides from the same research lineage and are frequently studied in parallel, Selank for anxiolytic-like endpoints and Semax for neurotrophic expression. One vial holds both under matched handling.
Has the combination been characterised as a single formulation?
No. Each peptide is characterised separately and no interaction data exists for the pair.
What sizes are available?
Two: 5 mg of each peptide, and 10 mg of each. The ratio is equal parts in both.
What purity is documented?
Each lot is analysed by reverse-phase HPLC and released at ≥99%, with a Certificate of Analysis.
How is it stored?
Store lyophilized at -20°C for long-term stability, protected from light and moisture, and avoid repeated freeze-thaw cycles.
Related monographs
For laboratory research use only. Not a drug, supplement, or medical product; not for human or animal use. All findings referenced are from published preclinical/laboratory research.